This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (56)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ANDRE BARBEAU, M.D.

Arch Neurol. 1961;4(1):97-102.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In July 1957, at the First International Congress of Neurological Sciences in Brussels, J. N. Cumings summarized the state of our knowledge on the biochemistry of basal ganglia diseases in one sentence: "The biochemical pathologist has so far been of practical assistance to the clinical neurologist and to the patient in only one of the group of extrapyramidal disorders, namely hepato-lenticular degeneration."¹

Progress in the understanding of Wilson's disease, which had been hesitant for many years,² has been rapid and constant since 1957 but very little has been added to the biochemistry of the other basal ganglia diseases. For that reason we feel that some recent developments in this field must be brought to the attention of neurologists. As is well known, biochemical changes in mental disease, especially alterations in catechol-amine and serotonin metabolism, are becoming increasingly important, and it may be that the present findings will give . . . [Full Text PDF of this Article]

Author Affiliations
MONTREAL

From the Laboratoire des Sciences Neurologiques, Faculté de Médecine, Université de Montréal.

Footnotes
Received for publication Aug. 8, 1960.

Assistant Professor of Neurological Sciences, University of Montreal.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?